Reply to: Caution Needed Before Adopting Reduced-Dose Elective Neck Irradiation in Head and Neck Cancer: A Response to UPGRADE-RT

Sven van den Bosch; Gerjon Hannink; Johannes H.A.M. Kaanders

doi:10.1200/jco-25-01390

Reply to: Caution Needed Before Adopting Reduced-Dose Elective Neck Irradiation in Head and Neck Cancer: A Response to UPGRADE-RT

S Sven van den Bosch (Sven van den Bosch, MD, PhD, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands; Gerjon Hannink, PhD, Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands; and Johannes H.A.M. Kaanders, MD, PhD, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands) G Gerjon Hannink (Sven van den Bosch, MD, PhD, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands; Gerjon Hannink, PhD, Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands; and Johannes H.A.M. Kaanders, MD, PhD, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands) J Johannes H.A.M. Kaanders

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Journal of Clinical Oncology

Volume / Issue Vol. 43, Issue 26

Published September 10, 2025

Pages 2953-2954

DOI 10.1200/jco-25-01390

ISSN 0732-183X

Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (3)

S

Sven van den Bosch

Sven van den Bosch, MD, PhD, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands; Gerjon Hannink, PhD, Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands; and Johannes H.A.M. Kaanders, MD, PhD, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands

G

Gerjon Hannink

Sven van den Bosch, MD, PhD, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands; Gerjon Hannink, PhD, Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands; and Johannes H.A.M. Kaanders, MD, PhD, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands

J

Johannes H.A.M. Kaanders

Reply to: Caution Needed Before Adopting Reduced-Dose Elective Neck Irradiation in Head and Neck Cancer: A Response to UPGRADE-RT

Article Details

Journal Info

Authors (3)

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer